Compare Unichem Lab with Natco Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs NATCO PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB NATCO PHARMA UNICHEM LAB/
NATCO PHARMA
 
P/E (TTM) x 61.3 15.6 393.7% View Chart
P/BV x 0.7 3.1 21.5% View Chart
Dividend Yield % 2.1 1.5 144.2%  

Financials

 UNICHEM LAB   NATCO PHARMA
EQUITY SHARE DATA
    UNICHEM LAB
Mar-19
NATCO PHARMA
Mar-18
UNICHEM LAB/
NATCO PHARMA
5-Yr Chart
Click to enlarge
High Rs2921,080 27.0%   
Low Rs182671 27.1%   
Sales per share (Unadj.) Rs167.7592.1 28.3%  
Earnings per share (Unadj.) Rs-3.6188.4 -1.9%  
Cash flow per share (Unadj.) Rs5.9206.3 2.9%  
Dividends per share (Unadj.) Rs4.008.25 48.5%  
Dividend yield (eoy) %1.70.9 179.1%  
Book value per share (Unadj.) Rs372.3833.6 44.7%  
Shares outstanding (eoy) m70.3836.90 190.7%   
Bonus/Rights/Conversions ESOPIS-  
Price / Sales ratio x1.41.5 95.6%   
Avg P/E ratio x-65.34.6 -1,404.5%  
P/CF ratio (eoy) x39.94.2 939.9%  
Price / Book Value ratio x0.61.1 60.6%  
Dividend payout %-110.24.4 -2,515.9%   
Avg Mkt Cap Rs m16,68032,311 51.6%   
No. of employees `0002.64.8 53.9%   
Total wages/salary Rs m2,3933,256 73.5%   
Avg. sales/employee Rs Th4,535.24,522.5 100.3%   
Avg. wages/employee Rs Th919.8674.0 136.5%   
Avg. net profit/employee Rs Th-98.21,439.0 -6.8%   
INCOME DATA
Net Sales Rs m11,80121,848 54.0%  
Other income Rs m984404 243.6%   
Total revenues Rs m12,78522,252 57.5%   
Gross profit Rs m-8359,284 -9.0%  
Depreciation Rs m674662 101.8%   
Interest Rs m75154 48.8%   
Profit before tax Rs m-6008,872 -6.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m-3431,920 -17.9%   
Profit after tax Rs m-2566,952 -3.7%  
Gross profit margin %-7.142.5 -16.6%  
Effective tax rate %57.321.6 264.7%   
Net profit margin %-2.231.8 -6.8%  
BALANCE SHEET DATA
Current assets Rs m20,38421,307 95.7%   
Current liabilities Rs m5,0295,920 85.0%   
Net working cap to sales %130.170.4 184.8%  
Current ratio x4.13.6 112.6%  
Inventory Days Days10573 143.0%  
Debtors Days Days135107 126.6%  
Net fixed assets Rs m9,02314,986 60.2%   
Share capital Rs m141369 38.2%   
"Free" reserves Rs m26,05830,353 85.9%   
Net worth Rs m26,19930,760 85.2%   
Long term debt Rs m00-   
Total assets Rs m31,49637,151 84.8%  
Interest coverage x-7.058.6 -11.9%   
Debt to equity ratio x00-  
Sales to assets ratio x0.40.6 63.7%   
Return on assets %-0.619.1 -3.0%  
Return on equity %-1.022.6 -4.3%  
Return on capital %-2.029.3 -6.8%  
Exports to sales %69.40-   
Imports to sales %00-   
Exports (fob) Rs m8,188NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m8,18810,322 79.3%   
Fx outflow Rs m5962,978 20.0%   
Net fx Rs m7,5927,343 103.4%   
CASH FLOW
From Operations Rs m-3,2784,636 -70.7%  
From Investments Rs m-2,860-11,155 25.6%  
From Financial Activity Rs m-246,509 -0.4%  
Net Cashflow Rs m-4,690-18 26,056.7%  

Share Holding

Indian Promoters % 50.1 52.0 96.3%  
Foreign collaborators % 0.0 1.5 -  
Indian inst/Mut Fund % 15.1 7.8 192.6%  
FIIs % 3.0 16.6 18.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 26.0 121.9%  
Shareholders   20,176 25,395 79.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   PFIZER  GSK PHARMA  PLETHICO PHARMA  WYETH LTD  ABBOTT INDIA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

NATCO PHARMA Announces Quarterly Results (1QFY20); Net Profit Down 21.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 21.1% YoY). Sales on the other hand came in at Rs 5 bn (down 8.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY20); Net Profit Up 102.2% (Quarterly Result Update)

Jul 30, 2019 | Updated on Jul 30, 2019

For the quarter ended June 2019, UNICHEM LAB has posted a net profit of Rs 5 m (up 102.2% YoY). Sales on the other hand came in at Rs 2 bn (up 15.4% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB 2018-19 Annual Report Analysis (Annual Result Update)

Jul 4, 2019 | Updated on Jul 4, 2019

Here's an analysis of the annual report of UNICHEM LAB for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of UNICHEM LAB. Also includes updates on the valuation of UNICHEM LAB.

UNICHEM LAB Announces Quarterly Results (4QFY19); Net Profit Up 31.7% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, UNICHEM LAB has posted a net profit of Rs 37 m (up 31.7% YoY). Sales on the other hand came in at Rs 3 bn (up 35.1% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

NATCO PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 59.8% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, NATCO PHARMA has posted a net profit of Rs 1 bn (down 59.8% YoY). Sales on the other hand came in at Rs 5 bn (down 40.6% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Finally, Is the Share Price of Yes Bank Ready for a Rebound?(The 5 Minute Wrapup)

Oct 7, 2019

Here's what every individual investor must know about Yes Bank...

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Oct 18, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB 5-YR ANALYSIS

COMPARE UNICHEM LAB WITH

MARKET STATS